Transchem Ltd
Incorporated in 1976, Transchem Ltd is engaged in the business of Mushroom production and processing.
- Market Cap ₹ 211 Cr.
- Current Price ₹ 172
- High / Low ₹ 194 / 33.1
- Stock P/E 71.9
- Book Value ₹ 66.2
- Dividend Yield 0.00 %
- ROCE 9.11 %
- ROE 6.75 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 2.60 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 4.91% over last 3 years.
- Earnings include an other income of Rs.7.13 Cr.
- Company has high debtors of 385 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.05 | -0.20 | -0.00 | 0.34 | 2.57 | 2.42 | |
| 1.04 | 0.78 | 0.93 | 0.98 | 1.69 | 1.18 | 1.39 | 1.88 | 2.54 | 1.73 | 2.08 | 4.03 | 5.25 | |
| Operating Profit | -1.04 | -0.78 | -0.93 | -0.98 | -1.69 | -1.18 | -1.39 | -1.93 | -2.74 | -1.73 | -1.74 | -1.46 | -2.83 |
| OPM % | -511.76% | -56.81% | -116.94% | ||||||||||
| 1.84 | 2.09 | 1.97 | 1.78 | 2.11 | 2.75 | 2.76 | 26.82 | 6.66 | 4.24 | 7.40 | 8.53 | 7.13 | |
| Interest | 0.05 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Depreciation | 1.52 | 1.07 | 1.02 | 1.02 | 0.97 | 0.80 | 0.57 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Profit before tax | -0.77 | 0.24 | 0.02 | -0.22 | -0.55 | 0.77 | 0.80 | 24.77 | 3.91 | 2.50 | 5.65 | 7.06 | 4.30 |
| Tax % | 5.19% | 45.83% | -150.00% | -0.00% | 116.36% | 61.04% | 47.50% | 2.50% | 26.60% | 50.80% | 25.66% | 26.06% | |
| -0.80 | 0.12 | 0.05 | -0.22 | -1.19 | 0.31 | 0.41 | 24.15 | 2.87 | 1.24 | 4.20 | 5.23 | 2.93 | |
| EPS in Rs | -0.65 | 0.10 | 0.04 | -0.18 | -0.97 | 0.25 | 0.33 | 19.73 | 2.34 | 1.01 | 3.43 | 4.27 | 2.40 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 290% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 46% |
| 5 Years: | 68% |
| 3 Years: | 38% |
| TTM: | -49% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 60% |
| 3 Years: | 100% |
| 1 Year: | 385% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 5% |
| Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 |
| Reserves | 25.99 | 26.11 | 26.15 | 25.75 | 24.57 | 25.74 | 24.53 | 50.70 | 54.06 | 53.60 | 63.41 | 67.08 | 68.75 |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| 0.29 | 0.22 | 0.23 | 0.17 | 0.17 | 0.39 | 0.30 | 0.48 | 0.51 | 0.39 | 0.66 | 0.40 | 0.61 | |
| Total Liabilities | 38.52 | 38.57 | 38.62 | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 81.60 |
| 9.47 | 8.40 | 7.42 | 6.40 | 5.43 | 4.27 | 3.70 | 0.11 | 0.10 | 0.09 | 0.09 | 0.05 | 0.05 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 25.93 | 27.50 | 28.01 | 29.79 | 10.21 | 5.93 | 3.69 | 8.69 | 8.82 | 8.23 | 8.91 | 2.04 | 2.05 |
| 3.12 | 2.67 | 3.19 | 1.97 | 21.34 | 28.17 | 29.68 | 54.62 | 57.89 | 57.91 | 67.31 | 77.63 | 79.50 | |
| Total Assets | 38.52 | 38.57 | 38.62 | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 81.60 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.57 | 0.94 | 1.08 | 0.55 | -19.79 | 10.34 | -0.63 | -27.72 | 21.91 | 1.22 | -39.31 | 36.00 | |
| 0.96 | -1.21 | -0.26 | -1.51 | 19.78 | 5.73 | 0.67 | 23.06 | 0.60 | -0.94 | 5.12 | 6.02 | |
| -1.60 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| Net Cash Flow | -0.07 | -0.27 | 0.83 | -0.95 | -0.01 | 16.07 | 0.04 | -4.66 | 22.51 | 0.28 | -34.18 | 42.02 |
| Free Cash Flow | 0.57 | 0.94 | 1.04 | 0.55 | -19.79 | 10.53 | -0.63 | -1.79 | 21.91 | 1.22 | -39.31 | 36.53 |
| CFO/OP | -55% | -121% | -116% | -56% | 1,165% | -897% | -0% | 1,401% | -853% | -132% | 2,182% | -2,618% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0.00 | -0.00 | 440.15 | 384.88 | ||||||||
| Inventory Days | 35,770.00 | 32,485.00 | -511.00 | -273.75 | -0.00 | -0.00 | ||||||
| Days Payable | -0.00 | -0.00 | ||||||||||
| Cash Conversion Cycle | -511.00 | -273.75 | 440.15 | 384.88 | ||||||||
| Working Capital Days | 311,418.00 | 42,705.00 | 71,421.91 | 4,970.82 | ||||||||
| ROCE % | -1.83% | 0.63% | 0.05% | -0.58% | -1.47% | 1.63% | 2.03% | 4.61% | 4.22% | 3.50% | 7.99% | 9.11% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Active Manufacturing Plants Count |
|
||||||||||
| Revenue from Operations (Trading Performance) INR Lakhs |
|||||||||||
| Revenue per Employee INR Lakhs/Employee |
|||||||||||
| Number of Permanent Employees Count |
|||||||||||
| Purchase of Stock-In-Trade (Agricultural Goods) INR Lakhs |
|||||||||||
Documents
Announcements
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
1d - Transchem confirms non-applicability of Large Corporate framework for FY2026; outstanding borrowings were nil.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.
- Closure of Trading Window 24 Mar
- Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Feb
- Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025, Along With Limited Review Report. 7 Feb
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Operational Status:[1][2]
Company was in the business of Mushroom production and operated a 100% Export Oriented Unit from its manufacturing plant in Pune. But due to change in international horticulture scenario, the mushroom plant of company is non-operational since several years. In FY20, the manufacturing plant has been monetized by company after getting applicable legal consents and approvals. At present, management of company is looking forward for new opportunities to utilize the funds of company. Company has temporarily invested its funds in short term treasury operations.